Best of JACC: Cardiovascular Interventions

JACC and JACC-INTV 2019 Statistics, Updates, and Best Young Author Papers

David J. Moliterno, M.D.

Best Original Paper: Coronary Interventions

Habib Samady, M.D. FACC FSCAI

Best Original Paper: Structural Heart Disease

Vasilis C. Babaliaros, M.D.

Best Original Paper: Peripheral Interventions

Mehdi H. Shishehbor, D.O., MPH, PhD, FSCAI

Cardiovascular Professionals Symposium: Antithrombotic Pharmacology

Considerations With Impella Device Anticoagulation

Craig J. Beavers

Thinning the Evidence: SAPT vs. DAPT Post-PCI

Shannon Finks, PharmD

Reversing Course: Managing Anticoagulation and Antiplatelet Bleeding in the Peri-PCI Period

Paul P Dobesh, PharmD

Antithrombotic Therapy Post-TAVR

Howard C. Herrmann, M.D., MSCAI

Cangrelor: Friend or Foe—Antiplatelet Game-Changer

Steven Dunn, PharmD

Cangrelor: Friend or Foe— Not the CHAMPION We Hoped For

James Coons, PharmD

Cardiovascular Professionals Symposium: Growing a Structural Heart Program

Team Sport: Creating the Heart Team and Establishing a New Program

Janet Fredal Wyman, DNP, APRN, ACNS-BC, AACC

Keep Them Coming: Maintaining a Referral Base

Mohammad M. Ansari, MD, FSCAI

How Are We Doing? Quality Metrics and Registries

Andrea Price

Cardiovascular Professionals Symposium: Hemodynamics and SHOCK

Normal Cardiovascular Hemodynamics

Cathy Graham, R.N., M.S.N., M.B.A.

SCAI Classification of Cardiogenic Shock

David A. Baran, M.D., FSCAI

Left vs. Right Heart Cardiogenic Shock: What Are the Hemodynamics?

Jeff Jeff Davis, RCIS

Medical Treatment Options for Cardiogenic Shock: When Is It Time to Escalate to Mechanical Support?

Chris Domenico

Hemodynamic Support Options for Cardiogenic Shock

George W. Vetrovec, M.D., MSCAI

Case Studies: Hemodynamics and Shock

Morton J. Kern, M.D., MSCAI

Interventional Cardio-Oncology

Updates in Interventional Onco-Cardiology

Konstantinos Marmagkiolis, MD, MBA, FSCAI

Acute Coronary Syndrome in Cancer Patients: Special Considerations

Cezar A. Iliescu, MD, FSCAI

Stent Healing and Its Role in Premature DAPT Discontinuation in Cancer Patients

Erin Fender, M.D.

Structural Procedures: TAVR, the New Standard for Cancer Patients

Cezar A. Iliescu, MD, FSCAI

Pericardiocentesis: A Guide on How to Make It Safe in All Patients

Nicolas Palaskas, MD

Interventional Onco-Cardiology: Real-Life Experience in the No-Guideline Territory

Sara Cecilia Martinez, M.D., Ph.D., FSCAI

Platelet Count, Platelet Function (Thrombelastogram): Role and Limitations in Cancer Patients Undergoing Coronary Procedures

Konstantinos Charitakis, MD, FSCAI

Large Data Role in Interventional Onco-Cardiology: Validate Old Paths, Map New Paths, or Both?

Mamas A. Mamas, M.D., FRCP, FSCAI

SCAI Women in Innovations (SCAI-WIN) Symposium: Cases in Structural Heart Disease

Case Presentation

Poonam Velagapudi, MD MS, FSCAI

Case Presentation

Suzanne J. Baron, M.D., FSCAI

SCAI Women in Innovations (SCAI-WIN) Symposium: Structural Heart Intervention

TAVR: Indication, Outcomes, and Complications

Vivian Gar-Yan Ng, M.D., FSCAI

Tricuspid Regurgitation: When and How to Treat

Erin Fender, M.D.

Optimal Imaging for Structural Interventions

The Best of Circulation: Cardiovascular Interventions 2019

Identifying the Infarct-Related Artery in Patients With Non–ST-Segment–Elevation Myocardial Infarction

John Heitner, MD

Safety and Effectiveness of Coronary Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Stenoses

Ziad A. Ali, M.D., Ph.D.

2020 Scientific Sessions

Special Interest Groups